Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Cytochromes P450 catalyze the reduction of α,β-unsaturated aldehydes.

Amunom I, Dieter LJ, Tamasi V, Cai J, Conklin DJ, Srivastava S, Martin MV, Guengerich FP, Prough RA.

Chem Res Toxicol. 2011 Aug 15;24(8):1223-30. doi: 10.1021/tx200080b. Epub 2011 Jul 29.

2.

Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes.

Amunom I, Stephens LJ, Tamasi V, Cai J, Pierce WM Jr, Conklin DJ, Bhatnagar A, Srivastava S, Martin MV, Guengerich FP, Prough RA.

Arch Biochem Biophys. 2007 Aug 15;464(2):187-96. Epub 2007 Jun 8.

4.

4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human.

Marini S, Grasso E, Longo V, Puccini P, Riccardi B, Gervasi PG.

Xenobiotica. 2003 Jan;33(1):1-11.

PMID:
12519690
6.

Aldehyde reduction by cytochrome P450.

Amunom I, Srivastava S, Prough RA.

Curr Protoc Toxicol. 2011 May;Chapter 4:Unit4.37. doi: 10.1002/0471140856.tx0437s48.

7.

Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells.

Srivastava S, Conklin DJ, Liu SQ, Prakash N, Boor PJ, Srivastava SK, Bhatnagar A.

Atherosclerosis. 2001 Oct;158(2):339-50.

8.

Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.

Yamazaki H, Shaw PM, Guengerich FP, Shimada T.

Chem Res Toxicol. 1998 Jun;11(6):659-65.

PMID:
9625734
9.
10.

Metabolism of lipid derived aldehyde, 4-hydroxynonenal in human lens epithelial cells and rat lens.

Choudhary S, Srivastava S, Xiao T, Andley UP, Srivastava SK, Ansari NH.

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2675-82.

PMID:
12766072
11.

Identification of intermediate pathways of 4-hydroxynonenal metabolism in the rat.

Alary J, Fernandez Y, Debrauwer L, Perdu E, Guéraud F.

Chem Res Toxicol. 2003 Mar;16(3):320-7.

PMID:
12641432
13.

Mouse hepatic microsomal oxidation of aliphatic aldehydes (C8 to C11) to carboxylic acids.

Watanabe K, Matsunaga T, Narimatsu S, Yamamoto I, Yoshimura H.

Biochem Biophys Res Commun. 1992 Oct 15;188(1):114-9.

PMID:
1417834
14.

Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.

Spracklin DK, Thummel KE, Kharasch ED.

Drug Metab Dispos. 1996 Sep;24(9):976-83.

PMID:
8886607
15.

Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.

Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED.

J Pharmacol Exp Ther. 1997 Apr;281(1):400-11.

16.

Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.

Lakshmi VM, Zenser TV, Davis BB.

Drug Metab Dispos. 1997 Apr;25(4):481-8.

17.

Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics.

Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, Yang CS.

Chem Res Toxicol. 1993 Jul-Aug;6(4):511-8.

PMID:
8374050
19.
20.

Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal.

Srivastava S, Chandra A, Ansari NH, Srivastava SK, Bhatnagar A.

Biochem J. 1998 Feb 1;329 ( Pt 3):469-75.

Items per page

Supplemental Content

Write to the Help Desk